The detection rates of colorectal cancers between anti-FIRs antibodies and anti-p53 antibodies were the same (Figure 3D); however, anti-FIRs antibodies were detected even in the early stages of cancer detection (Figure 3A). This evidence concerns the gene TP53 and colorectal cancer.